A Silicon Valley founder built a telehealth company to make ADHD treatment as easy as ordering takeout, until federal prosecutors traced 37 million pills of Adderall back to the clinic. We follow Done from venture-backed startup to criminal conviction, and ask what the case means for how we diagnose and treats ADHD. Plus: a new FDA approval adds a third option to the ADHD reuptake-inhibitor family.CME: Take the CME Post-Test for this EpisodePublished On: 09/14/2026Duration: 13 minutes, 34 secondsChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Carlat Psychiatry Podcast
Medication or Therapy? A Clinical Framework for Substance Use Disorders
CBT-I: The First-Line Treatment for Chronic Insomnia with Dr. Donn Posner (Part 2 of 2)
CBT-I: The First-Line Treatment for Chronic Insomnia with Dr. Donn Posner (Part 1 of 2)
Adult ADHD 4: Other Causes
Get summaries like this every morning.
Free AI-powered recaps of The Carlat Psychiatry Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.